Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3 polyunsaturated fatty acid (PUFA) intake

American Heart Journal

Volumn 116, Issue 5 PART 1, 1988, Pages 1201-1206

  Mehta, Jawahar ^a,b,c   Lawson, Daniel ^a,b,c   Saldeen, Tom ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR;

ADULT; AGED; CLINICAL ARTICLE; HUMAN; LIPID BLOOD LEVEL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

AGED; CHOLESTEROL; COMPARATIVE STUDY; CORONARY DISEASE; DOUBLE-BLIND METHOD; FATTY ACIDS, UNSATURATED; FISH OILS; GLYCOPROTEINS; HUMAN; MALE; MIDDLE AGE; PLASMINOGEN ACTIVATORS; PLASMINOGEN INACTIVATORS; SUPPORT, NON-U.S. GOV'T; TRIGLYCERIDES;

EID: 0023812557     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(88)90440-1     Document Type: Article

References (27)

1. Fibrinolytic activity and coronary artery disease
2. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations
3. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
4. Studies on posttraumatic fibrinolysis inhibition by use of tissue plasminogen activator
5. Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions
6. Generation in plasma of a fast acting inhibitor of plasminogen activator in response to endotoxin stimulation
7. Plasminogen activator inhibitor in the blood of patients with coronary artery disease
8. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
9. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations
10. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model
11. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oil in patients with hypertriglyceridemia
12. Hypertriglyceridemia and hypercoagulability
13. Suppression by diets rich in fish oil of very low density lipoprotein production in man
14. The mechanism of the hypotriglyceridemic effect of dietary omega-3 fatty acids in man [Abstract]
15. An inhibitor of plasminogen activator in rabbit endothelial cells
16. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets
17. Inactivation of tissue plasminogen activator in plasma demonstration of a complex with a new rapid inhibitor
18. Haemostatic function and cardiovascular death: early results of a prospective study
19. Fibrinolytic capacity after venous stasis in patients undergoing aorto-coronary by-pass surgery: relation to shunt occlusion
20. Plasminogen activators and inhibitors of plasminogen activator after venous occlusion in patients with venous thrombosis
21. Impaired fibrinolytic response to exercise in patients with type-IV hyperlipoproteinaemia
22. Eicosapentaenoic acid. Its relevance in atherosclerosis and coronary artery disease
23. Enhancing effect of dietary supplementation with W-3 fatty acids on plasma fibrinolysis in normal subjects
24. Cholesterol and saturated fat content of fish oil (FO) preparations influences the hypolipidemic response in type IV hyperlipidemic patients
25. Dietary supplementation with omega-3 polyunsaturated fatty acids in patients with stable coronary heart disease. Effects on indices of platelet and neutrophil function and exercise performance